Surface Cross-Linking by Macromolecular Tethers Enhances Virus-like Particles’ Resilience to Mucosal Stress Factors-Reference-Cited by-同舟云学术

Surface Cross-Linking by Macromolecular Tethers Enhances Virus-like Particles’ Resilience to Mucosal Stress Factors

Published:2024-01-18 Issue:4 Volume:18 Page:3382-3396
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ali Ahmed¹,Ganguillet Suwannee¹,Turgay Yagmur¹^ORCID,Keys Timothy G.¹,Causa Erika²,Fradique Ricardo²,Lutz-Bueno Viviane³⁴^ORCID,Chesnov Serge⁵,Tan-Lin Chia-Wei⁵^ORCID,Lentsch Verena¹,Kotar Jurij²,Cicuta Pietro²^ORCID,Mezzenga Raffaele¹^ORCID,Slack Emma¹,Radiom Milad¹²^ORCID

Affiliation:

1. Department of Health Sciences and Technology, ETH Zürich, Zürich 8092, Switzerland

2. Biological and Soft Systems, Cavendish Laboratory, University of Cambridge, Cambridge CB3 0HE, U.K.

3. Paul Scherrer Institute (PSI), Villigen 5232, Switzerland

4. Laboratoire Léon Brillouin, CEA-CNRS (UMR-12), CEA Saclay, Université Paris-Saclay, Gif-sur-Yvette Cedex 91191, France

5. Functional Genomics Centre Zürich (FGCZ), University of Zürich/ETH Zürich, Zürich 8057, Switzerland

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Cystic Fibrosis Trust

Gebert R?f Stiftung

H2020 European Research Council

National Center for Competence in Research in Microbiomes

Botnar Research Centre for Child Health

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c10339

Reference76 articles.

1. Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

2. Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases

3. Development of a Virus-Like Particle-Based Anti-HER2 Breast Cancer Vaccine

4. Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice

5. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins